|
LEISHMANIASIS
Guest Editors : Dr C.P. Thakur & Dr
S.K. Bhattacharya
Editorials
Leishmaniasis research - the challenges ahead
C.P. Thakur
Elimination of leishmaniasis
(kala-azar) from the Indian subcontinent is
technically feasible &
operationally achievable
S.K. Bhattacharya, Dipika Sur, P.K. Sinha & Juntra Karbwang
Original Article
Pre- & post-treatment evaluation of immunological features in Indian
visceral leishmaniasis
(VL)
patients with HIV co-infection
P.K. Sinha, Sanjiva Bimal, S.K. Singh, Krishna Pandey
D.N. Gangopadhyay & S.K. Bhattacharya
Review Articles
Biology of Leishmania donovani
Glycobiology of Leishmania
donovani
Sumi Mukhopadhyay (nee Bandyopadhyay)
& Chitra Mandal
Topoisomerase research of kinetoplastid parasite
Leishmania,
with special reference to
development of therapeutics
Benu Brata Das, Nilkantha Sen, Somdeb Bose Dasgupta, Agneyo Ganguly
Rakhee Das & Hemanta K. Majumder
Apoptosis in Leishmania species
& its relevance to disease pathogenesis
Chandrima Shaha
Immune responses in kala-azar
Samiran Saha, Smriti Mondal, Antara Banerjee, Jayeeta Ghose
Sudipta Bhowmick & Nahid Ali
Pathophysiology of visceral leishmaniasis - some recent concepts
Nancy Malla & R.C. Mahajan
Epidemiology
The epidemiology of visceral leishmaniasis in Bangladesh: Prospects for
improved control
Caryn Bern & Rajib Chowdhury
Visceral leishmaniasis in the New World & Africa
Jonathan Berman
Diagnosis
Challenges in the diagnosis of post kala-azar dermal leishmaniasis
Poonam Salotra & Ruchi Singh
New developments in diagnosis of leishmaniasis
Sarman Singh
Visceral leishmaniasis (kala-azar): Challenges ahead
R.K. Singh, H.P. Pandey & S. Sundar
Clinical Studies
Visceral leishmaniasis - current therapeutic modalities
Shyam Sundar & Mitali Chatterjee
Childhood visceral leishmaniasis
S.K. Bhattacharya, Dipika Sur & Juntra Karbwang
Leishmania /HIV co-infections
in the second decade
Israel Cruz, Javier Nieto, Javier Moreno, Carmen Caņavate
Philippe Desjeux & Jorge Alvar
Drug unresponsiveness & combination therapy for kala-azar
T.K. Jha
Current scenario of drug development for leishmaniasis
Simon L. Croft, Karin Seifert & Vanessa Yardley
Drug resistance mechanisms in clinical isolates of
Leishmania
donovani
Neeloo Singh
Prevention
Leishmaniasis vaccine candidates for development: A global overview
Ali Khamesipour, Sima Rafati, Noushin Davoudi, Fereidoun Maboudi
& Farrokh Modabber
Animal models for vaccine studies for visceral leishmaniasis
Ravendra Garg & Anuradha Dube
Genetically modified live attenuated parasites as vaccines for leishmaniasis
Angamuthu Selvapandiyan, Robert Duncan, Alain Debrabant, Nancy Lee
G. Sreenivas, Poonam Salotra & Hira L. Nakhasi
Vector control in leishmaniasis
K. Kishore, V. Kumar, S. Kesari, D.S. Dinesh, A.J. Kumar
P. Das & S.K. Bhattacharya
Correspondence
Prevalence of visceral leishmania & HIV co-infection in Nepal
R.L. Gurubacharya, S.M. Gurubacharya, D.L. Gurubacharya
J. Quinkel & V.L. Gurubacharya
Classics in Leishmaniasis Research
History of kala-azar in India
P.C. Sen Gupta
(The Indian Medical Gazette;
May 1947; 281-6)
On the possibility of the occurrence of trypanosomiasis in India
Major W.B. Leishman
(The British Medical Journal;
May 30, 1903; 1252-4)
Memoranda :On the possibility of the occurrence of trypanosomiasis in India
C. Donovan
(The British Medical Journal;
July 11, 1903; 79)
Transmission of Indian kala-azar to man by the bites of
Phlebotomus
argentipes Ann. and Burn
C.S. Swaminath, H.E. Shortt & L.A.P. Anderson
(Indian J Med Res, July
1942; 30 :
473-7)
Book Review
Trends and research
in Leishmaniasis, with particular reference to kala-azar
Book Received
Some Forthcoming
Scientific Events
Announcement
Guidelines
for Contributors
Home
Page
|